Zobrazeno 1 - 10
of 502
pro vyhledávání: '"Second-generation antipsychotic"'
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 723-731 (2024)
Background: Second-generation antipsychotics (SGAs) frequently cause metabolic syndrome (MetS), which raises the risk of heart disease, type 2 diabetes, morbid obesity, atherosclerosis, and hypertension. MetS also impairs cognitive function in patien
Externí odkaz:
https://doaj.org/article/b28bcfc4ce6a4aae83f69059fde932d5
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1837-1848 (2024)
Sanghyuk Seo,1 Bridget E Healey,2 Ronae McLin,2 Naomi C Sacks,2 Carmela J Benson,1 Leslie Citrome3 1Medical Affairs Neuroscience, Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Titusville, NJ, USA; 2PRECISIONheor, Boston, MA, USA; 3Dep
Externí odkaz:
https://doaj.org/article/bcd40a22401b44bda3275a7e9af862a3
Publikováno v:
Telangana Journal of Psychiatry, Vol 10, Iss 1, Pp 83-85 (2024)
Quetiapine, a second-generation antipsychotic drug, commonly has very less propensity of extrapyramidal symptoms and has an added advantage of less risk of serum prolactin, weight gain, or metabolic syndrome than other second-generation antipsychotic
Externí odkaz:
https://doaj.org/article/fa1c977d54c843daa9b3893f1c3be233
Publikováno v:
Middle East Current Psychiatry, Vol 30, Iss 1, Pp 1-8 (2023)
Abstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s a
Externí odkaz:
https://doaj.org/article/86061dc8f79540bc88761d92abdc23c2
Autor:
Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abreu
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
It is known that inflammation worsen the course of schizophrenia and induce high clozapine serum levels. However, no study evaluated this change in function of clozapine daily dose in schizophrenia. We assessed the correlation between inflammation an
Externí odkaz:
https://doaj.org/article/d0a8af711bc64b56945a9294dbcf2d4f
Autor:
Aleksandr M. Reznik, Timur S. Syunyakov, Aleksandr V. Mudrak, Nikolay B. Zakharov, Zhanna B. Popova, Anastasia N. Khoroshilova, Ilona G. Khurbatova, Alina M. Saifulina, Anton M. Eliseenko, Tatiana K. Matvievskaya, Angelina N. Khannanova
Publikováno v:
Consortium Psychiatricum, Vol 4, Iss 1, Pp 18-36 (2023)
BACKGROUND: Depression in patients with schizophrenia worsens the course of the disease by increasing the risk of suicide, by complicating the clinical picture of the disorder, and by reducing the quality of the social functioning; its treatment is d
Externí odkaz:
https://doaj.org/article/44ac73b5bf4d4cafa29772746852bc35
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 59, Iss 1, Pp 1-10 (2023)
Abstract Background The second-generation antipsychotics (SGAs) are a group of antipsychotic drugs, used to treat psychiatric conditions. SGAs have been shown to precipitate rapid weight gain and dyslipidemia, as well as to promote insulin resistance
Externí odkaz:
https://doaj.org/article/3c5b5cfd518d46f88fcc773b1b0aad9a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alexander M. Reznik, Timur S. Syunyakov, Inessa Yu. Akhmerova, Daniil Yu. Butylin, Anastasia O. Vasilenko, Anton N. Gvozdetckii, Tagir R. Gizatullin, Galina V. Gilmanshina, Egor A. Golosov, Sergey A. Kolchev, Lidiya P. Linova, Daniil V. Miron, Aleksandr V. Mudrak, Igor V. Oleichik, Stepan V. Sizov, Elena A. Tarakanova, Olga I. Chesnokova
Publikováno v:
Consortium Psychiatricum, Vol 3, Iss 3, Pp 58-72 (2022)
AIM: We endeavored to evaluate the efficacy of Lurasidone at doses of 40160 mg per day on symptoms of schizophrenia associated with symptoms of depression in real clinical practice in a Russian patient population. METHODS: One hundred sixty eight
Externí odkaz:
https://doaj.org/article/8cfd1e7396ad423cb4a91f19be601388
Autor:
María Ortega-Ruiz, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Francisco Abad-Santos, Pablo Zubiaur
Publikováno v:
Future Pharmacology, Vol 2, Iss 3, Pp 276-286 (2022)
Quetiapine is a second-generation antipsychotic used for the treatment of schizophrenia, depression and bipolar disorder. The aim of this traditional review was to summarize the available pharmacogenetic information on this drug and to conclude about
Externí odkaz:
https://doaj.org/article/b9c61177476046fb8fd3c207e68813f0